Biotelemetry Inc (BEAT)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1010 SECOND AVENUE SAN DIEGO, CA 92101

Beam Therapeutics Inc. operates as a biotechnology company. The Company develops DNA base editing technologies for the treatment of human diseases. Beam Therapeutics serves customers in the State of Massachusetts.

Data as of 2021-04-03 11:14:07 -0400
Market Cap2.469 Billion Shares Outstanding34.311 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS0.482
Price/Sales5.63 Debt to Equity1.86 EBITDA97.878 Million
Price to Book Value6.23 Forward PE Enterprise Value2.537 Billion
Total Cash90.229 Million Current Debt68.012 Million Gross Profit270.939 Million
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date2021-02-25 Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from BEAT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 6 2 200.0% 4 (0.24%) 1 (0.06%) 300.0%
Funds Holding: 236 208 13.46% 65 (3.91%) 55 (3.42%) 18.18%
13F shares: 31.941 Million 32.638 Million -2.14% 12.468 Million 12.711 Million -1.91%
% Ownership 93.093 95.2638 -2.28% 36.3396 37.101 -2.05%
New Positions: 66 30 120.0% 25 13 92.31%
Increased Positions 55 72 -23.61% 10 15 -33.33%
Closed Positions 37 34 8.82% 14 7 100.0%
Reduced Positions 87 80 8.75% 24 20 20.0%
Total Calls 718.906 Thousand 346.828 Thousand 107.28% 408.6 Thousand 159.3 Thousand 156.5%
Total Puts 366.607 Thousand 160.995 Thousand 127.71% 85.8 Thousand 8.1 Thousand 959.26%
PUT/CALL Ratio 0.51 0.46 10.87% 0.21 0.05 320.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Biotelemetry Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding BEAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BEAT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RUBIN ROBERT J.

  • Director
 0 2021-02-09 2

GORMAN KIRK E

  • Director
 176,905 2021-02-09 2

RIMEL REBECCA W

  • Director
 0 2021-02-09 2

GETZ HEATHER C EVP, CFO & CAO

  • Officer
 0 2021-02-09 1

CAPPER JOSEPH H PRESIDENT & CEO

  • Officer
  • Director
 0 2021-02-09 1

CONTI ANTHONY JAMES

  • Director
 0 2021-02-09 2

BROADWAY FRED PRESIDENT BIOTEL HEART

  • Officer
 0 2021-02-09 1

FRICK JOSEPH A.

  • Director
 0 2021-02-09 2

HILL COLIN

  • Director
 0 2021-02-09 2

RIETIKER STEPHEN

  • Director
 0 2021-02-09 2

OLSON TIFFANY

  • Director
 0 2021-02-09 2

DIETCH LAURA N.

  • Director
 0 2021-02-09 2

WADHWA MANISH SVP & CMO

  • Officer
 0 2021-02-09 1

STOICA ANDREI G SVP & CTO

  • Officer
 0 2021-02-09 1

WISNIEWSKI DANIEL SVP, TECHNICAL OPERATIONS

  • Officer
 24,817 2020-02-18 0

FEROLA PETER SVP & GENERAL COUNSEL

  • Officer
 8,507 2019-12-31 0

HRENKO GEORGE SVP - HUMAN RESOURCES

  • Officer
 20,518 2017-02-27 0

GELDART MICHAEL SENIOR VICE PRESIDENT

  • Officer
 65,396 2015-06-17 0

AHRENS RONALD A

  • Director
 196,670 2015-04-30 0

PRYSTOWSKY ERIC N

  • Director
 129,174 2014-05-05 0

MCNAMARA ANNA SENIOR VICE PRES/CLINICAL OP.

  • Officer
 90,903 2013-02-19 0

GROPPER CHARLES SENIOR VICE PRESIDENT

  • Officer
 51,422 2012-02-21 0

SCHULER ANTHONY SENIOR VICE PRESIDENT

  • Officer
 25,121 2012-02-21 0

KASRAWI JAREER SENIOR VICE PRESIDENT

  • Officer
 26,075 2012-02-21 0

THURMAN RANDY H

  • Director
 264,766 2011-05-02 0

LEONE PHILIP SENIOR VICE PRESIDENT

  • Officer
 43,655 2011-03-04 0

MIDDLETON FRED A

  • Director
 256,902 2010-05-10 0

IMPERATO JOHN F SENIOR VICE PRESIDENT

  • Officer
 39,179 2010-05-10 0

MARGOLIES MATTHEW SENIOR VICE PRESIDENT, SALES

  • Officer
 27,381 2010-05-10 0

GALVAN MARTIN P CHIEF FINANCIAL OFFICER

  • Officer
 21,019 2009-10-23 0

MYERS WOODROW A JR

  • Director
 9,614 2009-01-22 0

SWEENEY JAMES M

  • Director
 635,966 2008-08-06 0

REIN HARRY T

  • Director
 No longer subject to file 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT V

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING V BETEILIGUNGS GMBH & CO KG

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

SANDERLING V LTD PARTNERSHIP

  • 10% Owner
 944,366 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT IV

SANDERLING (FERI TRUST) VENTURE PARTNERS IV, L.P.

SANDERLING IV LIMITED PARTNERSHIP

SANDERLING IV BIOMEDICAL CO INVESTMENT FUND L P

SANDERLING IV BIOMEDICAL L P

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

  • 10% Owner
 631,829 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING V BETEILIGUNGS GMBH & CO KG

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

SANDERLING V LTD PARTNERSHIP

  • 10% Owner
 716,018 2008-03-25 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT IV

SANDERLING VENTURES MANAGEMENT V

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

  • 10% Owner
 357,461 2008-03-25 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING IV LIMITED PARTNERSHIP

SANDERLING (FERI TRUST) VENTURE PARTNERS IV, L.P.

SANDERLING IV BIOMEDICAL CO INVESTMENT FUND L P

SANDERLING IV BIOMEDICAL L P

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

  • 10% Owner
 1,484,576 2008-03-25 0

GUIDANT INVESTMENT CORP

  • 10% Owner
 No longer subject to file 2008-03-25 0

COHEN ARIE PRESIDENT AND CEO

  • Officer
  • Director
 0 2008-03-18 0

GEROLAMO EMMANUEL SENIOR VP SALES & MARKETING

  • Officer
 0 2008-03-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund BEAT -152.0 shares, $-5853.52 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund BEAT -11.0 shares, $-423.61 2020-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund BEAT -861.0 shares, $-62060.88 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund BEAT -153.0 shares, $-5892.03 2020-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BEAT -800.0 shares, $-57664.0 2020-12-31 N-PORT
JPMorgan Trust I- JPMorgan Global Allocation Fund BEAT -21183.0 shares, $-1513737.18 2021-01-31 N-PORT
JPMorgan Trust I- JPMorgan Opportunistic Equity Long/Short Fund BEAT -142356.0 shares, $-10172759.76 2021-01-31 N-PORT

Elevate your investments